Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4532 | 1771 | 34.2 | 82% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
129 | 3 | CARDIAC & CARDIOVASCULAR SYSTEM//RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING//JOURNAL OF NUCLEAR CARDIOLOGY | 67226 |
437 | 2 | ACUTE CORONARY SYNDROME//CARDIAC & CARDIOVASCULAR SYSTEM//MYOCARDIAL INFARCTION | 16277 |
4532 | 1 | EPTIFIBATIDE//ABCIXIMAB//TIROFIBAN | 1771 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | EPTIFIBATIDE | authKW | 985480 | 6% | 58% | 98 |
2 | ABCIXIMAB | authKW | 982422 | 8% | 41% | 139 |
3 | TIROFIBAN | authKW | 897607 | 6% | 48% | 108 |
4 | GLYCOPROTEIN IIB IIIA INHIBITORS | authKW | 404015 | 4% | 38% | 62 |
5 | GLYCOPROTEIN IIB IIIA ANTAGONISTS | authKW | 287721 | 1% | 76% | 22 |
6 | GLYCOPROTEIN IIB IIIA | authKW | 243631 | 3% | 28% | 51 |
7 | GPIIB IIIA | authKW | 242573 | 3% | 24% | 58 |
8 | GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST | authKW | 199285 | 1% | 68% | 17 |
9 | GP IIB IIIA INHIBITORS | authKW | 193323 | 2% | 42% | 27 |
10 | PLATELET AGGREGATION INHIBITORS | authKW | 191875 | 4% | 16% | 70 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 24437 | 46% | 0% | 816 |
2 | Peripheral Vascular Diseases | 9864 | 22% | 0% | 394 |
3 | Hematology | 4956 | 17% | 0% | 295 |
4 | Pharmacology & Pharmacy | 1001 | 16% | 0% | 284 |
5 | Chemistry, Medicinal | 649 | 6% | 0% | 113 |
6 | Medicine, General & Internal | 205 | 7% | 0% | 118 |
7 | Emergency Medicine | 31 | 1% | 0% | 13 |
8 | Respiratory System | 29 | 2% | 0% | 30 |
9 | Chemistry, Organic | 25 | 4% | 0% | 62 |
10 | Medicine, Research & Experimental | 8 | 2% | 0% | 37 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARL EDYTH LINDNER CLIN CARDIOVASC | 68961 | 0% | 100% | 4 |
2 | HARRISON SURG S | 38789 | 0% | 75% | 3 |
3 | ZENTRUM MED MIKROBIOL TRANSFUS MED | 38789 | 0% | 75% | 3 |
4 | EXPT STN E400 3255 | 34480 | 0% | 100% | 2 |
5 | NW SURG ASSOCIATES | 34480 | 0% | 100% | 2 |
6 | MED SCI DEV | 22986 | 0% | 67% | 2 |
7 | EXPLORATORY 2 | 22162 | 0% | 43% | 3 |
8 | 1 98 | 17240 | 0% | 100% | 1 |
9 | ABT OUTCOMES | 17240 | 0% | 100% | 1 |
10 | ACUTE STROKE PROGRAM NEUROVASC | 17240 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 30183 | 3% | 3% | 57 |
2 | JOURNAL OF INVASIVE CARDIOLOGY | 16791 | 2% | 2% | 43 |
3 | AMERICAN HEART JOURNAL | 13962 | 6% | 1% | 108 |
4 | CIRCULATION | 9275 | 6% | 0% | 115 |
5 | EUROPEAN HEART JOURNAL SUPPLEMENTS | 7369 | 1% | 2% | 21 |
6 | AMERICAN JOURNAL OF CARDIOLOGY | 6765 | 6% | 0% | 103 |
7 | THROMBOSIS AND HAEMOSTASIS | 5741 | 3% | 1% | 58 |
8 | THROMBOSIS RESEARCH | 5588 | 3% | 1% | 58 |
9 | CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS | 4415 | 2% | 1% | 37 |
10 | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 3756 | 3% | 0% | 59 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EPTIFIBATIDE | 985480 | 6% | 58% | 98 | Search EPTIFIBATIDE | Search EPTIFIBATIDE |
2 | ABCIXIMAB | 982422 | 8% | 41% | 139 | Search ABCIXIMAB | Search ABCIXIMAB |
3 | TIROFIBAN | 897607 | 6% | 48% | 108 | Search TIROFIBAN | Search TIROFIBAN |
4 | GLYCOPROTEIN IIB IIIA INHIBITORS | 404015 | 4% | 38% | 62 | Search GLYCOPROTEIN+IIB+IIIA+INHIBITORS | Search GLYCOPROTEIN+IIB+IIIA+INHIBITORS |
5 | GLYCOPROTEIN IIB IIIA ANTAGONISTS | 287721 | 1% | 76% | 22 | Search GLYCOPROTEIN+IIB+IIIA+ANTAGONISTS | Search GLYCOPROTEIN+IIB+IIIA+ANTAGONISTS |
6 | GLYCOPROTEIN IIB IIIA | 243631 | 3% | 28% | 51 | Search GLYCOPROTEIN+IIB+IIIA | Search GLYCOPROTEIN+IIB+IIIA |
7 | GPIIB IIIA | 242573 | 3% | 24% | 58 | Search GPIIB+IIIA | Search GPIIB+IIIA |
8 | GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST | 199285 | 1% | 68% | 17 | Search GLYCOPROTEIN+IIB+IIIA+RECEPTOR+ANTAGONIST | Search GLYCOPROTEIN+IIB+IIIA+RECEPTOR+ANTAGONIST |
9 | GP IIB IIIA INHIBITORS | 193323 | 2% | 42% | 27 | Search GP+IIB+IIIA+INHIBITORS | Search GP+IIB+IIIA+INHIBITORS |
10 | PLATELET AGGREGATION INHIBITORS | 191875 | 4% | 16% | 70 | Search PLATELET+AGGREGATION+INHIBITORS | Search PLATELET+AGGREGATION+INHIBITORS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SCARBOROUGH, RM , GRETLER, DD , (2000) PLATELET GLYCOPROTEIN IIB-IIIA ANTAGONISTS AS PROTOTYPICAL INTEGRIN BLOCKERS: NOVEL PARENTERAL AND POTENTIAL ORAL ANTITHROMBOTIC AGENTS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 43. ISSUE 19. P. 3453 -3473 | 106 | 66% | 68 |
2 | HANSON, J , DE LEVAL, X , KOLH, P , SUPURAN, C , PIROTTE, B , DOGNE, JN , (2003) UPDATE ON GPIIB/IIIA ANTAGONISTS.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 13. ISSUE 8. P. 1173-1188 | 77 | 77% | 1 |
3 | COLLER, BS , (2001) ANTI-GPIIB/IIIA DRUGS: CURRENT STRATEGIES AND FUTURE DIRECTIONS.THROMBOSIS AND HAEMOSTASIS. VOL. 86. ISSUE 1. P. 427 -443 | 79 | 63% | 124 |
4 | IBBOTSON, T , MCGAVIN, JK , GOA, KL , (2003) ABDXIMAB - AN UPDATED REVIEW OF ITS THERAPEUTIC USE IN PATIENTS WITH ISCHAEMIC HEART DISEASE UNDERGOING PERCUTANEOUS CORONARY REVASCULARISATION.DRUGS. VOL. 63. ISSUE 11. P. 1121-1163 | 72 | 66% | 30 |
5 | ASTER, RH , CURTIS, BR , BOUGIE, DW , (2004) THROMBOCYTOPENIA RESULTING FROM SENSITIVITY TO GPIIB-IIIA INHIBITORS.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 30. ISSUE 5. P. 569-577 | 50 | 91% | 10 |
6 | BOSCH, X , MARRUGAT, J , SANCHIS, J , (2013) PLATELET GLYCOPROTEIN IIB/IIIA BLOCKERS DURING PERCUTANEOUS CORONARY INTERVENTION AND AS THE INITIAL MEDICAL TREATMENT OF NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROMES.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 10. P. - | 78 | 45% | 0 |
7 | SCHROR, K , WEBER, AA , (2003) COMPARATIVE PHARMACOLOGY OF GP IIB/IIIA ANTAGONISTS.JOURNAL OF THROMBOSIS AND THROMBOLYSIS. VOL. 15. ISSUE 2. P. 71-80 | 50 | 85% | 52 |
8 | BOSCH, X , MARRUGAT, J , SANCHIS, J , (2013) PLATELET GLYCOPROTEIN IIB/IIIA BLOCKERS DURING PERCUTANEOUS CORONARY INTERVENTION AND AS THE INITIAL MEDICAL TREATMENT OF NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROMES.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 11. P. - | 76 | 45% | 0 |
9 | SCHNEIDER, DJ , (2011) ANTI-PLATELET THERAPY: GLYCOPROTEIN IIB-IIIA ANTAGONISTS.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 72. ISSUE 4. P. 672 -682 | 50 | 66% | 11 |
10 | ANDRONATI, SA , KARASEVA, TL , KRYSKO, AA , (2004) PEPTIDOMIMETICS - ANTAGONISTS OF THE FIBRINOGEN RECEPTORS: MOLECULAR DESIGN, STRUCTURES, PROPERTIES AND THERAPEUTIC APPLICATIONS.CURRENT MEDICINAL CHEMISTRY. VOL. 11. ISSUE 9. P. 1183-1211 | 65 | 57% | 45 |
Classes with closest relation at Level 1 |